- Home
- AEG vs RVMD Comparison
AEG vs RVMD Comparison
Compare AEG & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEG
- RVMD
- Stock Information
- Founded
- AEG 1983
- RVMD 2014
- Country
- AEG Netherlands
- RVMD United States
- Employees
- AEG N/A
- RVMD N/A
- Industry
- AEG Life Insurance
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEG Finance
- RVMD Health Care
- Exchange
- AEG Nasdaq
- RVMD Nasdaq
- Market Cap
- AEG 9.8B
- RVMD 10.2B
- IPO Year
- AEG N/A
- RVMD 2020
- Fundamental
- Price
- AEG $6.26
- RVMD $56.78
- Analyst Decision
- AEG Strong Buy
- RVMD Strong Buy
- Analyst Count
- AEG 1
- RVMD 13
- Target Price
- AEG N/A
- RVMD $57.00
- AVG Volume (30 Days)
- AEG 3.3M
- RVMD 1.5M
- Earning Date
- AEG 11-15-2024
- RVMD 11-06-2024
- Dividend Yield
- AEG 5.58%
- RVMD N/A
- EPS Growth
- AEG N/A
- RVMD N/A
- EPS
- AEG N/A
- RVMD N/A
- Revenue
- AEG $13,637,629,914.00
- RVMD $742,000.00
- Revenue This Year
- AEG N/A
- RVMD N/A
- Revenue Next Year
- AEG $1.86
- RVMD $300.00
- P/E Ratio
- AEG N/A
- RVMD N/A
- Revenue Growth
- AEG N/A
- RVMD N/A
- 52 Week Low
- AEG $5.35
- RVMD $20.98
- 52 Week High
- AEG $6.96
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- AEG 44.13
- RVMD 58.47
- Support Level
- AEG $6.27
- RVMD $53.69
- Resistance Level
- AEG $6.53
- RVMD $62.40
- Average True Range (ATR)
- AEG 0.10
- RVMD 2.21
- MACD
- AEG -0.03
- RVMD -0.43
- Stochastic Oscillator
- AEG 10.34
- RVMD 35.48
About AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings company listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the business that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.